Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Resonance Health.
RELATED STOCKHEAD STORIES
News
In Case You Missed It: Resource tech snags the lead and a $1.55m BHP deal
Health & Biotech
ASX Health Stocks: Resonance Health jumps 25pc on global pharma contract
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: Rock chips and Real Estate help keep the ASX fall to just 0.68pc for the day
Health & Biotech
ASX Health Stocks: Invex granted orphan drug designation in Europe; Resonance has a new CEO
Health & Biotech
Check Up: The TGA is 100pc cool with the world’s first faecal transplant, oral delivery being studied
Health & Biotech
ASX Health Stocks: Patent updates from Cynata and Proteomics; Ramsay sees good times ahead
News
Market highlights and 5 ASX small caps to watch on Monday
Health & Biotech
ASX Health Stocks: Resonance gets green light in US
Health & Biotech
ASX Health Stocks: Weed stock Cann Group gets licence from TGA for its cannabis facility
Health & Biotech
Check up: 78 biotech companies rocked the boat this week but only one has real news
News
December ASX Winners Column: Health and telco stocks plus recapitalised resources companies won the month
Health & Biotech
Check Up: Neuren close to FDA drug approval and Compumedics fires up Aussie factory for medical wearables
Health & Biotech
ASX Health Stocks: Alcidion wins Aussie government contract, while Resonance seeks US FDA nod
Health & Biotech
ASX Health: 4D Medical jumps 16pc on lungs device rollout, Proteomics up 10pc on UK deal
Health & Biotech
ASX Health Stocks: Cannabis play AusCann commences study of CBD on spinal cord injury
News